Drug profile · INN
icotrokinra hydrochloride
ICOTYDE
icotrokinra hydrochloride (ICOTYDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — icotrokinra hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 2
- Data quality
- 0.84
Quick answer
icotrokinra hydrochloride (ICOTYDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
Frequently asked questions
What is icotrokinra hydrochloride?
icotrokinra hydrochloride (ICOTYDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for icotrokinra hydrochloride?
ICOTYDE is a marketed brand name for icotrokinra hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of icotrokinra hydrochloride?
icotrokinra hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.